PDCD1LG2 and paraganglioma: Their data suggest that PD‐L2 has a more predominant role than PD‐L1 in shaping the immune‐tolerogenic environment, given the highly significant association with key pathways involved in innate, adaptive immunity, and inflammation in pheochromocytomas and paragangliomas.